skip to main content
Show Results with:

Safety and efficacy of teneligliptin, a dipeptidyl peptidase-4 inhibitor, in monotherapy and in combination therapy with antihyperglycemic agents in patients with type 2 diabetes mellitus —An interim analysis of post-marketing surveillance, RUBY—

Kadowaki, T.

Yakuri to chiryo: Basic pharmacology & therapeutics. Volume 46:Part 4 (2018, April); pp 481-498 -- Raifu Saiensu Shuppan

Check library holdings

Searching Remote Databases, Please Wait